Industry: Medical Devices & Consumables
Published Date: 2025-09-10
Pages: 116 Pages
Report ld: 4930833
Request Sample
Customized Report
In Vivo Imaging Systems Market Size(US$)

CAGR 2025-2031
3.1%
Market Size,2031
USD 169
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global In Vivo Imaging Systems market size was US$ 137 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on In Vivo Imaging Systems market competitiveness, regional economic performance, and supply chain configurations.
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Small animal in vivo imaging technology is a non-invasive method widely used in biomedical research, which can observe and track biological processes in small animals in real time. Through this technology, researchers can gain a deep understanding of dynamic changes such as disease progression, drug response and gene expression. Common in vivo imaging technologies include optical imaging, magnetic resonance imaging (MRI), positron emission tomography (PET), etc. This technology helps to reduce the use of experimental animals, provide more efficient and accurate experimental data, and promote the development of new drugs and the study of disease mechanisms. The main manufacturers of small animal in vivo imaging systems (In Vivo Imaging Systems) in the world include Perkin Elmer, Canon Medical Systems, Bruker, Idexx Laboratories and Hallmarq Veterinary Imaging, etc. The top five manufacturers account for about 47% of the global market share. In terms of revenue, North America is the largest market, accounting for about 64% of the market share. In terms of product type, optical imaging is the largest segment, accounting for about 65% of the revenue share, and in terms of downstream, laboratories are the largest downstream field, accounting for 78% of the revenue share. In the small animal in vivo imaging industry, manufacturers need to take multiple measures to promote technological innovation and enhance market competitiveness. First, manufacturers should focus on technology research and development, and continuously improve the resolution, sensitivity and multimodal functions of imaging equipment so that they can more accurately capture biological processes in small animals. In addition, manufacturers should focus on developing user-friendly software platforms to ensure the automation and simplicity of data acquisition and analysis to reduce the operational burden of researchers and improve experimental efficiency. Secondly, manufacturers should strengthen cooperation with scientific research institutions and pharmaceutical companies to meet the needs of different industries and fields through customized solutions. For example, in cutting-edge fields such as cancer research, new drug development and gene therapy, providing targeted imaging equipment and services can effectively expand the market. At the same time, manufacturers should also pay attention to the cost-effectiveness of equipment, while maintaining high-quality imaging performance, by optimizing production processes and supply chains, reducing the manufacturing cost of equipment, making in vivo imaging technology more economically feasible, and attracting more small and medium-sized laboratories to use it. In addition, with the increasing global attention to animal welfare, manufacturers also need to ensure that their equipment complies with ethical standards and regulations, reduce unnecessary harm to experimental animals, and provide more accurate non-invasive imaging technology to help researchers achieve more humane experimental design. Finally, manufacturers should establish a comprehensive after-sales service system to provide equipment maintenance, technical support and operation training to ensure that users can use the equipment in a long-term and stable manner. Through a comprehensive layout in technology, cooperation, cost, ethics and service, manufacturers can maintain a sustained competitive advantage in the small animal in vivo imaging industry, meet the growing needs of scientific researchers and pharmaceutical companies, and promote the advancement of biomedical research.
The global In Vivo Imaging Systems market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of In Vivo Imaging Systems market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., MRI in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pet Hospital and Clinic in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the In Vivo Imaging Systems value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 In Vivo Imaging Systems Product Scope
1.2 In Vivo Imaging Systems by Type
1.2.1 Global In Vivo Imaging Systems Sales by Type (2020 & 2024 & 2031)
1.2.2 Optical Imaging
1.2.3 MRI
1.2.4 Ultrasound
1.2.5 Others
1.3 In Vivo Imaging Systems by Application
1.3.1 Global In Vivo Imaging Systems Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Laboratory
1.3.3 Pet Hospital and Clinic
1.4 Global In Vivo Imaging Systems Market Estimates and Forecasts (2020-2031)
1.4.1 Global In Vivo Imaging Systems Market Size in Value Growth Rate (2020-2031)
1.4.2 Global In Vivo Imaging Systems Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global In Vivo Imaging Systems Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global In Vivo Imaging Systems Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global In Vivo Imaging Systems Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global In Vivo Imaging Systems Sales Market Share by Region (2020-2025)
2.2.2 Global In Vivo Imaging Systems Revenue Market Share by Region (2020-2025)
2.3 Global In Vivo Imaging Systems Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global In Vivo Imaging Systems Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global In Vivo Imaging Systems Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America In Vivo Imaging Systems Market Size and Prospective (2020-2031)
2.4.2 Europe In Vivo Imaging Systems Market Size and Prospective (2020-2031)
2.4.3 China In Vivo Imaging Systems Market Size and Prospective (2020-2031)
2.4.4 Japan In Vivo Imaging Systems Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global In Vivo Imaging Systems Historic Market Review by Type (2020-2025)
3.1.1 Global In Vivo Imaging Systems Sales by Type (2020-2025)
3.1.2 Global In Vivo Imaging Systems Revenue by Type (2020-2025)
3.1.3 Global In Vivo Imaging Systems Price by Type (2020-2025)
3.2 Global In Vivo Imaging Systems Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global In Vivo Imaging Systems Sales Forecast by Type (2026-2031)
3.2.2 Global In Vivo Imaging Systems Revenue Forecast by Type (2026-2031)
3.2.3 Global In Vivo Imaging Systems Price Forecast by Type (2026-2031)
3.3 Different Types In Vivo Imaging Systems Representative Players
4 Global Market Size by Application
4.1 Global In Vivo Imaging Systems Historic Market Review by Application (2020-2025)
4.1.1 Global In Vivo Imaging Systems Sales by Application (2020-2025)
4.1.2 Global In Vivo Imaging Systems Revenue by Application (2020-2025)
4.1.3 Global In Vivo Imaging Systems Price by Application (2020-2025)
4.2 Global In Vivo Imaging Systems Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global In Vivo Imaging Systems Sales Forecast by Application (2026-2031)
4.2.2 Global In Vivo Imaging Systems Revenue Forecast by Application (2026-2031)
4.2.3 Global In Vivo Imaging Systems Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in In Vivo Imaging Systems Application
5 Competition Landscape by Players
5.1 Global In Vivo Imaging Systems Sales by Players (2020-2025)
5.2 Global Top In Vivo Imaging Systems Players by Revenue (2020-2025)
5.3 Global In Vivo Imaging Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Imaging Systems as of 2024)
5.4 Global In Vivo Imaging Systems Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of In Vivo Imaging Systems, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of In Vivo Imaging Systems, Product Type & Application
5.7 Global Key Manufacturers of In Vivo Imaging Systems, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America In Vivo Imaging Systems Sales by Company
6.1.1.1 North America In Vivo Imaging Systems Sales by Company (2020-2025)
6.1.1.2 North America In Vivo Imaging Systems Revenue by Company (2020-2025)
6.1.2 North America In Vivo Imaging Systems Sales Breakdown by Type (2020-2025)
6.1.3 North America In Vivo Imaging Systems Sales Breakdown by Application (2020-2025)
6.1.4 North America In Vivo Imaging Systems Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe In Vivo Imaging Systems Sales by Company
6.2.1.1 Europe In Vivo Imaging Systems Sales by Company (2020-2025)
6.2.1.2 Europe In Vivo Imaging Systems Revenue by Company (2020-2025)
6.2.2 Europe In Vivo Imaging Systems Sales Breakdown by Type (2020-2025)
6.2.3 Europe In Vivo Imaging Systems Sales Breakdown by Application (2020-2025)
6.2.4 Europe In Vivo Imaging Systems Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China In Vivo Imaging Systems Sales by Company
6.3.1.1 China In Vivo Imaging Systems Sales by Company (2020-2025)
6.3.1.2 China In Vivo Imaging Systems Revenue by Company (2020-2025)
6.3.2 China In Vivo Imaging Systems Sales Breakdown by Type (2020-2025)
6.3.3 China In Vivo Imaging Systems Sales Breakdown by Application (2020-2025)
6.3.4 China In Vivo Imaging Systems Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan In Vivo Imaging Systems Sales by Company
6.4.1.1 Japan In Vivo Imaging Systems Sales by Company (2020-2025)
6.4.1.2 Japan In Vivo Imaging Systems Revenue by Company (2020-2025)
6.4.2 Japan In Vivo Imaging Systems Sales Breakdown by Type (2020-2025)
6.4.3 Japan In Vivo Imaging Systems Sales Breakdown by Application (2020-2025)
6.4.4 Japan In Vivo Imaging Systems Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Perkin Elmer
7.1.1 Perkin Elmer Company Information
7.1.2 Perkin Elmer Business Overview
7.1.3 Perkin Elmer In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Perkin Elmer In Vivo Imaging Systems Products Offered
7.1.5 Perkin Elmer Recent Development
7.2 Canon Medical Systems
7.2.1 Canon Medical Systems Company Information
7.2.2 Canon Medical Systems Business Overview
7.2.3 Canon Medical Systems In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Canon Medical Systems In Vivo Imaging Systems Products Offered
7.2.5 Canon Medical Systems Recent Development
7.3 Bruker
7.3.1 Bruker Company Information
7.3.2 Bruker Business Overview
7.3.3 Bruker In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Bruker In Vivo Imaging Systems Products Offered
7.3.5 Bruker Recent Development
7.4 Idexx Laboratories
7.4.1 Idexx Laboratories Company Information
7.4.2 Idexx Laboratories Business Overview
7.4.3 Idexx Laboratories In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Idexx Laboratories In Vivo Imaging Systems Products Offered
7.4.5 Idexx Laboratories Recent Development
7.5 Hallmarq Veterinary Imaging
7.5.1 Hallmarq Veterinary Imaging Company Information
7.5.2 Hallmarq Veterinary Imaging Business Overview
7.5.3 Hallmarq Veterinary Imaging In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Hallmarq Veterinary Imaging In Vivo Imaging Systems Products Offered
7.5.5 Hallmarq Veterinary Imaging Recent Development
7.6 Huantong Nuclear Magnet
7.6.1 Huantong Nuclear Magnet Company Information
7.6.2 Huantong Nuclear Magnet Business Overview
7.6.3 Huantong Nuclear Magnet In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Huantong Nuclear Magnet In Vivo Imaging Systems Products Offered
7.6.5 Huantong Nuclear Magnet Recent Development
7.7 Sunny Optical
7.7.1 Sunny Optical Company Information
7.7.2 Sunny Optical Business Overview
7.7.3 Sunny Optical In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Sunny Optical In Vivo Imaging Systems Products Offered
7.7.5 Sunny Optical Recent Development
7.8 Photon
7.8.1 Photon Company Information
7.8.2 Photon Business Overview
7.8.3 Photon In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Photon In Vivo Imaging Systems Products Offered
7.8.5 Photon Recent Development
7.9 MILABS
7.9.1 MILABS Company Information
7.9.2 MILABS Business Overview
7.9.3 MILABS In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.9.4 MILABS In Vivo Imaging Systems Products Offered
7.9.5 MILABS Recent Development
7.10 iThera Medical
7.10.1 iThera Medical Company Information
7.10.2 iThera Medical Business Overview
7.10.3 iThera Medical In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.10.4 iThera Medical In Vivo Imaging Systems Products Offered
7.10.5 iThera Medical Recent Development
7.11 Vieworks
7.11.1 Vieworks Company Information
7.11.2 Vieworks Business Overview
7.11.3 Vieworks In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Vieworks In Vivo Imaging Systems Products Offered
7.11.5 Vieworks Recent Development
7.12 Aspect Imaging
7.12.1 Aspect Imaging Company Information
7.12.2 Aspect Imaging Business Overview
7.12.3 Aspect Imaging In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Aspect Imaging In Vivo Imaging Systems Products Offered
7.12.5 Aspect Imaging Recent Development
7.13 TOMOWAVE
7.13.1 TOMOWAVE Company Information
7.13.2 TOMOWAVE Business Overview
7.13.3 TOMOWAVE In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.13.4 TOMOWAVE In Vivo Imaging Systems Products Offered
7.13.5 TOMOWAVE Recent Development
7.14 Trifoil Imaging
7.14.1 Trifoil Imaging Company Information
7.14.2 Trifoil Imaging Business Overview
7.14.3 Trifoil Imaging In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Trifoil Imaging In Vivo Imaging Systems Products Offered
7.14.5 Trifoil Imaging Recent Development
7.15 Clinx
7.15.1 Clinx Company Information
7.15.2 Clinx Business Overview
7.15.3 Clinx In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Clinx In Vivo Imaging Systems Products Offered
7.15.5 Clinx Recent Development
7.16 Raylight
7.16.1 Raylight Company Information
7.16.2 Raylight Business Overview
7.16.3 Raylight In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Raylight In Vivo Imaging Systems Products Offered
7.16.5 Raylight Recent Development
7.17 Spectral Instruments Imaging
7.17.1 Spectral Instruments Imaging Company Information
7.17.2 Spectral Instruments Imaging Business Overview
7.17.3 Spectral Instruments Imaging In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Spectral Instruments Imaging In Vivo Imaging Systems Products Offered
7.17.5 Spectral Instruments Imaging Recent Development
7.18 Novel Medical
7.18.1 Novel Medical Company Information
7.18.2 Novel Medical Business Overview
7.18.3 Novel Medical In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Novel Medical In Vivo Imaging Systems Products Offered
7.18.5 Novel Medical Recent Development
7.19 Tanon
7.19.1 Tanon Company Information
7.19.2 Tanon Business Overview
7.19.3 Tanon In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Tanon In Vivo Imaging Systems Products Offered
7.19.5 Tanon Recent Development
7.20 Biolight
7.20.1 Biolight Company Information
7.20.2 Biolight Business Overview
7.20.3 Biolight In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.20.4 Biolight In Vivo Imaging Systems Products Offered
7.20.5 Biolight Recent Development
7.21 PINGSENG Healthcare
7.21.1 PINGSENG Healthcare Company Information
7.21.2 PINGSENG Healthcare Business Overview
7.21.3 PINGSENG Healthcare In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.21.4 PINGSENG Healthcare In Vivo Imaging Systems Products Offered
7.21.5 PINGSENG Healthcare Recent Development
7.22 Fujifilm Visualsonics
7.22.1 Fujifilm Visualsonics Company Information
7.22.2 Fujifilm Visualsonics Business Overview
7.22.3 Fujifilm Visualsonics In Vivo Imaging Systems Sales, Revenue and Gross Margin (2020-2025)
7.22.4 Fujifilm Visualsonics In Vivo Imaging Systems Products Offered
7.22.5 Fujifilm Visualsonics Recent Development
8 In Vivo Imaging Systems Manufacturing Cost Analysis
8.1 In Vivo Imaging Systems Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of In Vivo Imaging Systems
8.4 In Vivo Imaging Systems Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 In Vivo Imaging Systems Distributors List
9.3 In Vivo Imaging Systems Customers
10 In Vivo Imaging Systems Market Dynamics
10.1 In Vivo Imaging Systems Industry Trends
10.2 In Vivo Imaging Systems Market Drivers
10.3 In Vivo Imaging Systems Market Challenges
10.4 In Vivo Imaging Systems Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global In Vivo Imaging Systems market size was US$ 141 million in 2025 and is forecast to reach a readjusted size of US$ 174 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 119
USD 4250.00
(Single User License)
The global In Vivo Imaging Systems market was valued at US$ 141 million in 2025 and is anticipated to reach US$ 174 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 146
USD 2900.00
(Single User License)
The global market for In Vivo Imaging Systems was estimated to be worth US$ 141 million in 2025 and is projected to reach US$ 174 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 165
USD 3950.00
(Single User License)
The global In Vivo Imaging Systems market is projected to grow from US$ 137 million in 2024 to US$ 169 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 184
USD 4900.00
(Single User License)
The global market for In Vivo Imaging Systems was estimated to be worth US$ 137 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 157
USD 3950.00
(Single User License)
The global market for In Vivo Imaging Systems was valued at US$ 137 million in the year 2024 and is projected to reach a revised size of US$ 169 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-01-19
Pages: 111
USD 2900.00
(Single User License)
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published Date: 2024-09-08
Pages: 174
USD 4350.00
(Single User License)
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published Date: 2024-09-08
Pages: 160
USD 3950.00
(Single User License)
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published Date: 2024-09-08
Pages: 190
USD 4900.00
(Single User License)
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published Date: 2024-09-08
Pages: 116
USD 2900.00
(Single User License)
The global In Vivo Imaging Systems market size was US$ 141 million in 2025 and is forecast to reach a readjusted size of US$ 174 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 119
The global In Vivo Imaging Systems market was valued at US$ 141 million in 2025 and is anticipated to reach US$ 174 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-05
Pages: 146
The global market for In Vivo Imaging Systems was estimated to be worth US$ 141 million in 2025 and is projected to reach US$ 174 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-01-05
Pages: 165
The global In Vivo Imaging Systems market is projected to grow from US$ 137 million in 2024 to US$ 169 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 184
The global market for In Vivo Imaging Systems was estimated to be worth US$ 137 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 157
The global market for In Vivo Imaging Systems was valued at US$ 137 million in the year 2024 and is projected to reach a revised size of US$ 169 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-01-19
Pages: 111
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published: 2024-09-08
Pages: 174
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published: 2024-09-08
Pages: 160
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published: 2024-09-08
Pages: 190
Small animal living body imaging technology refers to the application of imaging methods to carry out qualitative and quantitative research on biological processes at the tissue, cell and molecular levels in the living state. In vivo imaging is one of the techniques for long-term longitudinal study of animals without damaging them. Imaging technology can provide absolute quantitative and relative quantitative data. It changes according to its position in the sample. This kind of technology provides absolute quantitative information, such as CT, MRI and pet; Image data signals are sample position dependent, such as bioluminescence, fluorescence and multiphoton microscopy in visible light imaging, which belong to the category of relative quantification, but can be quantified by strictly designing experiments.
Published: 2024-09-08
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now